Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $19.3000 (-7.66%) ($18.6100 - $22.1000) on Mon. Jan. 29, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.82% (three month average) | RSI | 64 | Latest Price | $19.3000(-7.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) EWI(8%) PEJ(8%) SKYY(8%) TBT(8%) | Factors Impacting CAPR price | CAPR will decline at least -2.91% in a week (0% probabilities). GLD(-9%) TLT(-8%) GDX(-8%) SLV(-7%) SIL(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.91% (StdDev 5.82%) | Hourly BBV | 0 () | Intraday Trend | -9.8% | | | |
|
5 Day Moving Average | $17.88(7.94%) | 10 Day Moving Average | $17.3(11.56%) | 20 Day Moving Average | $16.89(14.27%) | To recent high | -29.8% | To recent low | 32.2% | Market Cap | $380m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |